The US Food and Drug Administration has cleared Corindus Vascular Robotics’ CorPath system for use in peripheral vascular interventions.
Studies have indicated that patterns of restenosis affect long-term outcomes following retreatment in the superficial femoral artery. Gary Ansel, OhioHealth/Riverside Methodist Hospital, Columbus, USA, presented results at the Leipzig Interventional Course (LINC; 26–29 January 2016, Leipzig, Germany) showing that, when in-stent restenosis occurs, it is more often focal with a drug-eluting stent (Zilver PTX, Cook Medical), whereas it is more diffuse with bare metal stents. The drug-eluting device, according to Ansel, yields less restenosis, less reintervention and reduced plaque burden.
Two studies presented at the European Congress of Radiology (2–6 March, Vienna, Austria) have found that radiofrequency ablation could have a role in the treatment of thyroid nodules.
Boehringer Ingelheim has announced the enrolment of the first patient in RE-COVERY DVT/PE, a global observational study on the management of deep vein thrombosis (DVT) and pulmonary embolism (PE).
The Mount Sinai Hospital, New York City, USA has become the first in the country to offer radiopaque bead treatment for liver cancer patients. The minimally invasive treatment using the M1 Lumi Bead loaded with doxorubicin, is now available for patients with inoperable and difficult-to-treat liver cancer.
The US Food and Drug Administration has announced a proposal to ban most powdered gloves in the USA. While use of these gloves is decreasing, they pose an unreasonable and substantial risk of illness or injury to health care providers, patients and other individuals who are exposed to them, which cannot be corrected through new or updated labelling, according to an FDA news release.
The Netherlands Healthcare Institute has approved reimbursement of radioembolization for patients with colorectal liver metastases who have failed prior treatment. The institute based its decision on the clinical evidence of the efficacy and safety of SIR-Spheres (Sirtex) Y-90 resin microspheres for treating this patient group, a press release from Sirtex says.
“Charles Dotter’s vision transformed the diagnostic catheter into a therapeutic tool and set the foundation for image-guided intervention, and as interventionalists, we have attempted to make the scalpel obsolete by employing technology to treat patients non-operatively. However, today, there is another revolution occurring—theranostics,” said Alan Matsumoto, during his delivery of the Charles J Tegtmeyer Lecture at the International Symposium on Endovascular Therapy (ISET, Hollywood, USA) 2016.
A study presented at the European Congress of Radiology (2–6 March, Vienna, Austria) set out to investigate any procedural or anatomical factors that might affect the technical outcome of prostatic artery embolization.
A study presented at the Symposium on Clinical Oncology (CIO, Hollywood, USA) noted that the hepatitis C virus is a cause of significant morbidity and mortality in the USA. However, the study findings report that treatment regimens have improved in recent years.
Silk Road Medical has been granted CE approval for its Enroute transcarotid neuroprotection system (NPS). The company has also reported the first patients have been treated with the system.
Although systemic thrombolysis achieves similar rates of mortality as catheter-directed intervention for the treatment of acute pulmonary embolism, it also carries “significantly increased odds of intracranial haemorrhagic complications,” according to data presented at the American Venous Forum (AVF; 24–26 February, Orlando, USA).
AngioDynamics has signed an agreement with Merz North America, US affiliates of the global Merz Pharma Group. AngioDynamics is to serve as the exclusive distributor of the Asclera polidocanol injection within the US vein market.
“EVRF (F Care Systems) saphenous ablation is a safe and painless procedure for the treatment of the greater saphenous vein and/or small saphenous vein,” according to recently released data. The authors, led by Attila Szabo, VP-Med Health and Education Centre, Budapest, Hungary, write that “high patient acceptance and minimal postoperative discomfort allows a quick return to work and normal life for patients.”
A few months ago a discussion on the LinkedIn page of the American College of Phlebology caught my attention: “Medicare: maximum four endovenous laser therapies per lifetime?”
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos